Terazosin
- Product NDC
- 33261-870
- 11-digit product format
- 332610870
- Labeler code
- 33261
- Product ID
- 33261-870_ce7c1472-b399-493e-a419-e71701b04acc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aidarex Pharmaceuticals LLC
- Application
- ANDA075498
- Marketing category
- ANDA
- Marketing start
- 2001-04-12
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 33261-870-30 | Terazosin | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | | 1 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 33261-870 | TERAZOSIN CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | Legacy NDC, 1 package rows | 20140213_06234cba-c474-4f53-8efa-fa688b6913b6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 33261-870-30 | 33261087030 | 30 in 1 BOTTLE, PLASTIC | Historical |